Biontech Se Stock Filter Stocks by Fundamentals

BNTX Stock  USD 92.97  1.27  1.38%   
BioNTech SE fundamentals help investors to digest information that contributes to BioNTech's financial success or failures. It also enables traders to predict the movement of BioNTech Stock. The fundamental analysis module provides a way to measure BioNTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioNTech stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

BioNTech Shares Owned by Institutions Analysis

BioNTech Shares Owned by Institutions Driver Correlations

Understanding the fundamental principles of building solid financial models for BioNTech is extremely important. It helps to project a fair market value of BioNTech Stock properly, considering its historical fundamentals such as Shares Owned by Institutions. Since BioNTech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BioNTech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BioNTech's interrelated accounts and indicators.
0.821.00.62-0.930.990.940.690.820.760.960.860.751.00.580.810.671.01.00.86
0.820.790.34-0.640.760.630.960.380.30.650.980.280.850.860.380.60.790.820.67
1.00.790.62-0.951.00.950.650.830.780.970.840.780.990.530.830.661.01.00.85
0.620.340.62-0.530.60.80.270.790.740.670.490.720.590.330.780.720.620.60.85
-0.93-0.64-0.95-0.53-0.95-0.88-0.44-0.78-0.72-0.98-0.69-0.74-0.92-0.26-0.77-0.58-0.94-0.94-0.78
0.990.761.00.6-0.950.950.610.850.80.970.810.80.990.490.840.621.00.990.83
0.940.630.950.8-0.880.950.50.940.90.950.730.890.920.460.940.710.950.930.89
0.690.960.650.27-0.440.610.50.250.170.470.920.150.720.950.250.520.650.680.55
0.820.380.830.79-0.780.850.940.250.990.860.510.990.780.260.990.540.830.80.8
0.760.30.780.74-0.720.80.90.170.990.810.431.00.710.190.990.460.770.740.73
0.960.650.970.67-0.980.970.950.470.860.810.710.820.940.330.860.630.970.960.85
0.860.980.840.49-0.690.810.730.920.510.430.710.410.890.850.50.670.840.860.77
0.750.280.780.72-0.740.80.890.150.991.00.820.410.710.160.990.450.770.740.71
1.00.850.990.59-0.920.990.920.720.780.710.940.890.710.60.770.660.991.00.84
0.580.860.530.33-0.260.490.460.950.260.190.330.850.160.60.260.520.540.560.51
0.810.380.830.78-0.770.840.940.250.990.990.860.50.990.770.260.590.830.790.79
0.670.60.660.72-0.580.620.710.520.540.460.630.670.450.660.520.590.660.660.84
1.00.791.00.62-0.941.00.950.650.830.770.970.840.770.990.540.830.661.00.86
1.00.821.00.6-0.940.990.930.680.80.740.960.860.741.00.560.790.661.00.85
0.860.670.850.85-0.780.830.890.550.80.730.850.770.710.840.510.790.840.860.85
Click cells to compare fundamentals
Competition

Based on the latest financial disclosure, BioNTech SE has a Shares Owned by Institutions of 0.0null. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Shares Owned by Institutions (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

BioNTech Institutional Holders

Institutional Holdings refers to the ownership stake in BioNTech that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of BioNTech's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing BioNTech's value.
Shares
Deutsche Bank Ag2023-09-30
546.5 K
Voloridge Investment Management, Llc2023-09-30
530.5 K
Millennium Management Llc2023-09-30
498.4 K
Clearbridge Advisors, Llc2023-09-30
484.1 K
Dekabank Deutsche Girozentrale2023-12-31
425.1 K
First Trust Advisors L.p.2023-12-31
416.9 K
Gilder Gagnon Howe & Co Llc2023-12-31
359.7 K
Bamco Inc2023-12-31
242.3 K
Fmr Inc2023-09-30
237.8 K
Baillie Gifford & Co Limited.2023-12-31
8.7 M
Primecap Management Company2023-12-31
4.8 M

BioNTech Fundamentals

About BioNTech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BioNTech SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioNTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioNTech SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany. Biontech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3082 people.

BioNTech Investors Sentiment

The influence of BioNTech's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in BioNTech. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to BioNTech's public news can be used to forecast risks associated with an investment in BioNTech. The trend in average sentiment can be used to explain how an investor holding BioNTech can time the market purely based on public headlines and social activities around BioNTech SE. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
BioNTech's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for BioNTech's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average BioNTech's news discussions. The higher the estimated score, the more favorable is the investor's outlook on BioNTech.

BioNTech Implied Volatility

    
  32.01  
BioNTech's implied volatility exposes the market's sentiment of BioNTech SE stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if BioNTech's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that BioNTech stock will not fluctuate a lot when BioNTech's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioNTech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioNTech's short interest history, or implied volatility extrapolated from BioNTech options trading.

Pair Trading with BioNTech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioNTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will appreciate offsetting losses from the drop in the long position's value.

Moving together with BioNTech Stock

  0.71MBRX Moleculin Biotech Upward RallyPairCorr
  0.72MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against BioNTech Stock

  0.85MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.83DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.78MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.71EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.66URGN UroGen Pharma Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to BioNTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioNTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioNTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioNTech SE to buy it.
The correlation of BioNTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioNTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioNTech SE moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioNTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether BioNTech SE offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioNTech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biontech Se Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biontech Se Stock:
Check out BioNTech Piotroski F Score and BioNTech Altman Z Score analysis.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for BioNTech Stock analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is BioNTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioNTech. If investors know BioNTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioNTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.80)
Earnings Share
4.16
Revenue Per Share
15.873
Quarterly Revenue Growth
(0.65)
Return On Assets
0.0262
The market value of BioNTech SE is measured differently than its book value, which is the value of BioNTech that is recorded on the company's balance sheet. Investors also form their own opinion of BioNTech's value that differs from its market value or its book value, called intrinsic value, which is BioNTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioNTech's market value can be influenced by many factors that don't directly affect BioNTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioNTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioNTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioNTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.